Searchable abstracts of presentations at key conferences on calcified tissues
Previous issue | Volume 6 | ICCBH2017 | Next issue

8th International Conference on Children's Bone Health

Poster Presentations

(1)

A 3-year longitudinal study of skeletal effects and growth in children after kidney transplantation
1Department of Pediatrics, Institute for Clinical Sciences, The Queen Silvia Children’s Hospital, The Sahlgrenska Academy at Göteborg University, Göteborg, Sweden; 2Department of Clinical Chemistry, Linköping University, Linköping, Sweden.
ba0006p002
Bone mass tracks into teenage years
1Hans Christian Andersen Children’s Hospital, Odense University Hospital, Odense, Denmark; 2Emergency Department, Hospital of Southern Jutland, Aabenraa, Denmark; 3Research of Childhood Health, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
ba0006p004
Muscular fitness, bone mineral density and hip geometry in young males: the PRO-BONE study
1IGOID Research Group, University of Castilla-La Mancha, Toledo, Spain; 2Children’s Health and Exercise Research Centre, Sport and Health Sciences, University of Exeter, Exeter, UK; 3Department of Preventive Medicine, School of Medicine of the University of Sao Paulo, São Paulo, Brazil; 4Growth, Exercise, Nutrition and Development Research Group, University of Zaragoza, Zaragoza, Spain; 5School of Nursing and Physiotherapy, University of Castilla La Mancha, Toledo, Spain; 6University of Exeter Medical School, Exeter, UK; 7School of Sport Sciences, European University, Madrid, Spain.
ba0006p005
Bone density and body composition in post-pubertal adolescents treated with GnRH analogues in a gender identity development service
Department of Paediatric Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK.
ba0006p006
Effects of a 8-month physical activity and nutrition-induced weight loss program on bone health of obese adolescents.
1Laboratory of the Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), Clermont-Ferrand, France; 2School of Exercise Science, Australian Catholic University, Strathfield, New South Wales, Australia; 3CRNH-Auvergne, Clermont-Ferrand, France; 4Department of Occupational Medicine, University Hospital CHU G. Montpied, Clermont-Ferrand, France; 5Department of Sport Medicine and Functional Explorations, University Hospital CHU G. Montpied, Clermont-Ferrand, France; 6UGECAM, SRR Nutrition-Obesity Center, Clermont-Ferrand, France.
ba0006p007
Cardiorespiratory fitness, bone mineral density and hip geometry in young males: the PRO-BONE study
1IGOID Research Group, University of Castilla-La Mancha, Toledo, Spain; 2Children’s Health and Exercise Research Centre. Sport and Health Sciences, University of Exeter, Exeter, UK; 3Department of Preventive Medicine, School of Medicine of the University of Sao Paulo, São Paulo, Brazil; 4Growth, Exercise, Nutrition and Development Research Group, University of Zaragoza, Zaragoza, Spain; 5School of Nursing and Physiotherapy, University of Castilla La Mancha, Toledo, Spain; 6University of Exeter Medical School, Exeter, UK; 7European University, School of Sport Sciences, Madrid, Spain.
ba0006p008
Sexual dimorphism in cortical bone morphology during adolescent growth in Chinese
1The Chinese University of Hong Kong, Hong Kong, Hong Kong; 2University of Melbourne, Melbourne, Australia.
ba0006p009
Transient hyperphosphatasemia in a child with nephrolithiasis And history of severe prematurity
1Department of Pediatrics, Klatovy Hospital, Klatovy, Czech Republic; 2Department of Pediatrics, Pardubice Hospital, Pardubice, Czech Republic; 3Department of Pediatrics, University Hospital and Faculty of Medicine, Charles University, Hradec Králové, Czech Republic; 4Department of Pediatrics, University Hospital and Faculty of Medicine, Charles University, Prague, Czech Republic.
ba0006p010
Neonatal hypocalcemia - transient neonatal pseudohypoparathyroidism
1Department Pediatrics, Klatovy Hospital, Klatovy, Czech Republic; 2Department of Clinical Biochemistry, Klatovy Hospital, Klatovy, Czech Republic; 3Bone Disease Center, Klatovy Hospital, Klatovy, Czech Republic.
ba0006p011
Determinants of bone outcomes in adolescent athletes at baseline: The PRO-BONE study
1University of Exeter, Exeter, UK; 2University of Castilla-La Mancha, Toledo, Spain; 3University of Thessaly, Trikala, Greece; 4University of Thrace, Komotini, Greece; 5University of Zaragoza, Zaragoza, Spain.
ba0006p012
Longitudinal evaluation of bone mass, geometry and metabolism in adolescent male athletes. The PRO-BONE study
Swolin-Eide Diana   Hansson Sverker   Magnusson Per   Ronne Maria   Heideman Malene   Schou Anders   Laursen Jens Ole   Wedderkopp Niels   Husby Steffen   Molgaard Christian   Ubago-Guisado Esther   Vlachopoulos Dimitris   de Moraes Augusto Cesar   Torres-Costoso Ana   Wilkinson Kelly   Metcalf Brad   Sanchez-Sanchez Javier   Gallardo Leonor   Gracia-Marco Luis   Tseretopoulou Xanthippi   Amin Nadia   Mushtaq Talat   Chaplais Elodie   Naughton Geraldine   Greene David   Duclos Martine   Masurier Julie   Dutheil Frederic   Thivel David   Courteix Daniel   Ubago-Guisado Esther   Vlachopoulos Dimitris   de Moraes Augusto Cesar   Torres-Costoso Ana   Wilkinson Kelly   Metcalf Brad   Sanchez-Sanchez Javier   Gallardo Leonor   Gracia-Marco Luis   Cheuk Ka-Yee   Wang Xiaofang   Yu Fiona W P   Tam Elisa M S   Ng Bobby K W   Ghasem-Zadeh Ali   Zebaze Roger   Seeman Ego   Cheng Jack C Y   Lam Tsz-Ping   Kutilek Stepan   Formanova Daniela   Senkerik Marian   Skalova Sylva   Markova Daniela   Langer Jan   Kutilek Stepan   Vracovska Martina   Pikner Richard   Fejfarkova Zlatka   Gracia-Marco Luis   Vlachopoulos Dimitris   Ubago-Guisado Esther   Barker Alan R   Fatouros Ioannis G   Avlotini Alexandra   Knapp Karen K   Moreno Luis A   Williams Craig A   Vlachopoulos Dimitris   Barker Alan R   Williams Craig A   Ubago-Guisado Esther   Ortega Francisco B   Ruiz Jonathan R   Moreno Luis A   Fatouros Ioannis G   Avloniti Alexandra   Gracia-Marco Luis  
1University of Exeter, Exeter, UK; 2University of Castilla-La Mancha, Toledo, Spain; 3University of Granada, Granada, Spain; 4University of Zaragoza, Zaragoza, Spain; 5University of Thessaly, Trikala, Greece; 6Democritus University of Thrace, Komotini, Greece.
ba0006p013
Longitudinal changes in bone mineral content and bone stiffness in adolescent male athletes: The PRO-BONE study
1University of Exeter, Exeter, UK; 2University of Castilla-La Mancha, Toledo, Spain; 3Universidad of Rosario, Bogota, Colombia; 4University of Santiago, Santiago, Chile; 5University of Cadiz, Cadiz, Spain; 6University of Granada, Granada, Spain; 7University of Zaragoza, Zaragoza, Spain.
ba0006p014
Structural geometry of bones is prominently associated with risk of fracture in children
1Erasmus MC, Rotterdam, The Netherlands; 2Beck Radiological Innovations, Inc., Baltimore, Maryland, USA; 3Lausanne University Hospital, Lausanne, Switzerland.
ba0006p015
Necrotizing enterocolitis during the neonatal period is related to lower bone mass at 5 years of age, compared to matched controls
Institution of Clinical Sciences, Department of Pediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
ba0006p016
Bone mineral density in children and adolescents with neurofibromatosis type I: mineralization during growth and pubertal development
1Endocrinology and Metabolic Diseases Unit, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; 2Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; 3Bone Metabolic Unit, Division of Nuclear Medicine, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy; 4Developmental Neurology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 5Pediatric Clinic, Università degli Studi di Perugia, Perugia, Italy.
ba0006p017
Zebrafish as model organism for craniosynostosis
Institut for Human Genetics, Würzburg, Germany.
ba0006p019
Age at onset of walking affects bone mineral content in early childhood
Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
ba0006p020
Bone densitometric parameters and body composition in preterm and term infants at the age of forty weeks of gestational age
1University of Genova, Genova, Italy; 2Endocrine Unit, Department of Pediatrics, Giannina Gaslini Institute, Genova, Italy.
ba0006p022
Tracking differences in morphology and regulation between the spine and long bones in a pig model
1Division of Pediatric Pulmonology, Allergology and Endocrinology, Department of Pediatrics & Adolescent Medicine, Medical University of Vienna, Vienna, Austria; 2Institute of Anatomy, Histology and Embryology, University of Veterinary Medicine Vienna, Vienna, Austria.
ba0006p023
Spondyloepiphyseal dysplasia: A rare cause of short stature
1Children’s Hospital P.A. Kyriakoy, Athens, Greece; 2Agia Sofia Children’s Hospital, Athens, Greece.
ba0006p024
The impact of Haemophilia A on bone health
1Department of Bone and Mineral Metabolism, Institute of Child Health, Athens, Greece; 2Haemophilia Center/Haemostasis Unit, ‘Aghia Sophia’ Children’s Hospital, Athens, Greece.
ba0006p025
Own research experience of bone tissue metabolism in patients with the Ehlers-Danlos syndrome
1Institute of Orthopedics and Traumatology, Kiev, Ukraine; 2Institute of Gerontology, Kiev, Ukraine.
ba0006p026
Sex and iron modify fibroblast growth factor 23 concentrations in 1-year-old children
1University of Helsinki, Helsinki, Finland; 2Helsinki University Hospital, Helsinki, Finland; 3Folkhälsan Research Centre, Helsinki, Finland.
ba0006p027
Web-based surveys using Patient-Reported Outcome Measurement Information System (PROMIS) instruments allow documentation of important components of the disease experience among individuals with Osteogenesis Imperfecta
1Children’s National Health System, Washington, District of Columbia, USA; 2University of South Florida, Tampa, Florida, USA; 3Osteogenesis Imperfecta Foundation, Gaithersburg, Maryland, USA; 4Texas Children’s Hospital, Houston, Texas, USA.
ba0006p029
Outcomes of zoledronic acid use in paediatric conditions
1Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; 2Monash University, Melbourne, Victoria, Australia; 3Royal Childrens Hospital, Melbourne, Victoria, Australia; 4Deakin University, Melbourne, Victoria, Australia.
ba0006p030
Valproic acid induces Fanconi syndrome and reversible hypophosphataemic rickets via upregulation of fibroblast growth factor 23
1Birmingham Children’s Hospital, Birmingham, UK; 2Royal Manchester Children’s Hospital, Manchester, UK; 3Leeds Children’s Hospital, Leeds, UK; 4University of Birmingham, Birmingham, UK.
ba0006p031
Bone health status in Indian children with type 1 diabetes as assessed by peripheral quantitative computer tomography (pQCT)
1Hirabai Cowasji Jehangir Medical Research Institute, Pune, Maharashtra, India; 2Royal Manchester Children’s Hospital, Manchester, UK.
ba0006p032
Nutritional status influence upon bone mineral density of children with cerebral palsy after reconstructive hip joint surgery
FSBI “Federal center of traumatology, orthopedics and endoprosthesis replacement” Ministry of Health of Russian Federation, Barnaul, Russia.
ba0006p033
Identification of bone remodelling alterations in Gorham-Stout disease
1Multifactorial Disease and Complex Phenotype Research Area, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; 2Rare Diseases and Medical Genetic Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; 3Division of Immunology and Infectious Diseases Department of Pediatrics, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; 4Department of Pediatric Hemathology and Oncology, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; 5Histopathology Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy.
ba0006p034
Decreased incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility
1APHP, Reference center for rare disorders of the mineral metabolism, filière OSCAR and Plateforme d’Expertise Maladies Rares Paris-Sud, Le Kremlin Bicêtre, France; 2APHP, Pitié-Salpetrière, Paris, France; 3APHP, Rett Center, Necker-Enfants Malades, Paris, France; 4INSERM U1169, Hôpital Bicêtre, Le Kremlin Bicêtre, et Université Paris-Saclay, Le Kremlin Bicêtre, France.
ba0006p036
Early fragility fractures in Zellweger syndrome spectrum - peroxisome dysfunction affecting osteogenesis?
1Department of Paediatric Endocrinology and Diabetes, Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK; 2Department of Paediatric Metabolic Medicine, Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK; 3Department of Clinical Genetics, St Michaels Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK; 4Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
ba0006p037
Hypophosphatasia associated with acute disseminated encephalomyelitis (ADEM): causal relationship or coincidence?
1Royal National Orthopaedic Hospital, Stanmore, UK; 2Great Ormond Street Hospital, London, UK; 3Glasgow Royal Infirmary, Glasgow, UK; 4Northwick Park Hospital, London, UK; 5Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain; 6Royal Manchester Childrens Hospital, Manchester, UK.
ba0006p038
Atypical femoral fractures in 2 children treated with bisphosphonates
1Royal National Orthopaedic Hospital, Stanmore, UK; 2Great Ormond Street Hospital, London, UK; 3Royal Manchester Childrens Hospital, Manchester, UK.
ba0006p040
Osteogenesis imperfecta type VI presenting as suspected physical abuse -- a report of two cases
1Academic Unit of Child Health, University of Sheffield, Sheffield, UK; 2Sheffield Children’s NHS Foundation Trust, Sheffield, UK; 3Community Paediatrics, Sherwood Forest Hospitals NHS Foundation Trust, Ashfield, UK; 4Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK; 5Sheffield Diagnostic Genetics Laboratory, Sheffield Children’s NHS Foundation Trust, Sheffield, UK; 6Mellanby Centre for Bone Health, Sheffield, UK; 7Sheffield Clinical Genetics Service, Sheffield Children’s NHS Foundation Trust, Sheffield, UK; 8St George’s University of London, London, UK.
ba0006p042
Pseudohypoparathyroidism type IB: A cause of late hypocalcemia
1Children’s Hospital P.A. Kyriakou, Athens, Greece; 2Faculty of Medicine Univ of Southampton, Southhampton, UK; 3INSERM, Paris, France.
ba0006p043
A rare cause of rickets
1Department of Endocrinology and Diabetes, Birmingham Children’s Hospital, Birmingham, UK; 2Department of Paediatric Endocrinology and Diabetes, Nottingham Children’s Hospital, Nottingham, UK; 3Department of Endocrinology and Diabetes, University Hospital Southampton, Southampton, UK; 4Department of Paediatric Endocrinology, Great Ormond Street Hospital, London, UK; 5Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
ba0006p048
Difficulties in diagnostics and clinical classification of osteogenesis imperfecta in Poland
1Department of Paediatric Propaedeutics and Bone Metabolic Diseases, Medical University of Lodz, Lodz, Poland; 2Central Clinical Hospital Medical Hospital of Lodz, Lodz, Poland.
ba0006p049
Low bone density and fragility fractures in unbalanced translocation T(9;11)
Bone Metabolism Unit, Experimental Laboratory for Children’s Bone Metabolism Research, Istituto Auxologico Italiano IRCCS, Milano, Italy.
ba0006p051
Hypophosphatasia - from symptom to diagnosis - case report
Department of Pediatric Propedeutic and Bone Metabolic Diseases Medical University of Lodz, Lodz, Poland.
ba0006p052
Determinants of bone density in Duchenne muscular dystrophy
1Bone Metabolism Unit, Experimental Laboratory for Children’s Bone Metabolism Research, Istituto Auxologico Italiano IRCCS, Milano, Italy; 2Child Neurology Unit, Istituto Nazionale Neurologico C. Besta IRCCS, Milano, Italy; 3Centro Clinico Nemo, Ospedale Niguarda, Milano, Italy; 4Istituto Medea IRCCS, La Nostra Famiglia, Bosisio Parini (LC), Italy; 5Dipartimento Neurologia Pediatrica, Policlinico Universitario “Agostino Gemelli” Università Cattolica, Roma, Italy; 6Centro Clinico Nemo Sud, U.O.C. di Neurologia e Malattie Neuromuscolari, Policlinico Universitario di Messina, Messina, Italy.
ba0006p053
The influence of immune dysregulation on bone metabolism in children with inflammatory bowel disease: the potential for bone as a secondary lymphoid organ
1Academic Unit of Child Health, University of Sheffield, Sheffield, South Yorkshire, UK; 2Department of Paediatric Gastroenterology, Sheffield Children’s Hospital, Sheffield, South Yorkshire, UK; 3John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, Nottinghamshire, UK.
ba0006p054
Conservative management of metabolic derangements in osseous tissue among patients with vitamin d-dependent rickets type 2
Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences, Kyiv, Ukraine.
ba0006p056
Zebrafish as a model for hypophosphatasia
1Orthopedic Department, Orthopedic Center for Musculoskeletal Research, University of Würzburg, Würzburg, Germany; 2Institute of Human Genetics, Biocentre University of Würzburg, Würzburg, Germany.
ba0006p057
The relationship between maternal and child bone density in Nigerian children with and without nutritional rickets
1Mayo Clinic, Rochester, MN, USA; 2University of the Witwatersrand, Johannesburg, South Africa; 3Jos University Teaching Hospital, Jos, Plateau State, Nigeria.
ba0006p058
Retrospective evaluation of serum alkaline phosphatases (ALP) in Italian children referred to a tertiary children's hospital
1Health Sciences Department, University of Florence, Anna Meyer Children’s University Hospital, Florence, Italy; 2Central Laboratory, Anna Meyer Children’s University Hospital, Florence, Italy.
ba0006p059
Renal tubular acidosis with an elevated urinary β-2 microglobulin in a boy presenting with sporadic hypophosphataemic rickets and intellectual disability (Dent's Disease)
1Department of Paediatrics, Monash University, Clayton, Victoria, Australia; 2Monash Children’s Hospital, Clayton, Victoria, Australia; 3Department of Paediatrics, Parkville, Victoria, Australia; 4AIMSS, University of Melbourne, Sunshine Hospital, St Albans, Victoria, Australia; 5Monash Genetics, Monash Health, Clayton, Victoria, Australia.
ba0006p061
Lysinuric protein intolerance presenting with short stature and osteoporosis
1School of Medicine, Karadeniz Technical University, Trabzon, Turkey; 2Ankara Hospital, Baskent University, Ankara, Turkey.
ba0006p062
Effects of KRN23, a fully human anti-FGF23 monoclonal antibody, on functional outcomes in children with X-linked hypophosphatemia (XLH): results from a randomized, open-label Phase 2 study
1Indiana University School of Medicine, Indianapolis, IN, USA; 2Yale University School of Medicine, New Haven, CT, USA; 3Hôpital Bicêtre, Le Kremlin-Bicêtre, France; 4University of Groningen, Groningen, The Netherlands; 5Birmingham Children’s Hospital, Birmingham, UK; 6Royal Manchester Children’s Hospital, Manchester, UK; 7Great Ormond Street Hospital, London, UK; 8University of California, San Francisco, San Francisco, CA, USA; 9Ultragenyx Pharmaceutical Inc., Novato, CA, USA; 10Shriners Hospital for Children, St Louis, MO, USA.
ba0006p063
A novel form of congenital rickets due to a recurrent gain of function mutation in CYP3A4
1Australian Institute for Musculoskeletal Science (AIMSS), University of Melbourne and Paediatric Department, Sunshine Hospital, St Albans 3021, Australia; 2Division of Endocrinology and Diabetes, The Children’s Hospital of Philadelphia, Philadelphia, PA, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; 3National Institute for Health Research (NIHR) Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK; 4Monash University, Monash Medical Centre, Clayton 3168, Australia; 5Paediatrician, 44 Docker Street, Wangaratta 3677, Australia; 6Birmingham Children’s Hospital and University of Birmingham, Birmingham, UK.
ba0006p065
Unusual presentation of acquired hypophosphataemic rickets
Department of Paediatrics, Chris Hani Baragwanath Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
ba0006p066
Mid-gestation anomaly scan cannot be relied upon for screening for severe perinatal hypophosphatasia
1Royal Manchester Children’s Hospital, Manchester, UK; 2St Mary’s Hospital, Manchester, UK.
ba0006p067
Craniosynostosis can occur in children with nutritional rickets
1Evelina London Children’s Hospital, London, UK; 2Sheffield Children’s Hospital, Sheffield, UK; 3Royal Manchester Children’s Hospital, Manchester, UK.
ba0006p068
The abnormally high and heterogeneous bone matrix mineralization after childhood solid organ transplantation is not further increased by bisphosphonate treatment
1Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Med. Department Hanusch Hospital, Vienna, Austria; 2Children’s Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland; 3Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA; 4Center for Molecular Medicine, Karolinska Institute and Clinical Genetics, Karolinska, University Hospital, Stockholm, Sweden.
ba0006p070
In search of hypophosphatasia: a need to establish normative data for low alkaline phosphatase in pediatric population
1Department of Pediatrics, Rheumatology, Immunology and Metabolic Bone Diseases, Medical University of Bialystok, Bialystok, Poland; 2Department of Pediatric Laboratory Diagnostics, Medical University of Bialystok, Bialystok, Poland.
ba0006p071
Spectrum of paediatric hypophosphataemic rickets in a tertiary centre
Leeds Teaching Hospitals NHS Trust, Leeds, UK.
ba0006p073
High bone turnover markers and disturbances of bone mineral density in children with hypophosphataemic rickets
1Department of Paediatric Propaedeutics and Bone Metabolic Diseases, Medical University of Lodz, Lodz, Poland; 2Central Clinical Hospital Medical University of Lodz, Lodz, Poland.
ba0006p074
Improvement of bone density in eating disorders correlates with improvements in growth
1University of Glasgow, Glasgow, UK; 2Greater Glasgow & Clyde NHS, Glasgow, UK.
ba0006p075
The role of bone age in the evaluation of trabecular bone score (TBS) of children and adolescents 5--19 years old
1Clinical Epidemiology Unit, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico; 2R&D Department, Med-Imaps, Pessac, France; 3CETIR Medical Centre, Barcelona, Spain.
ba0006p077
Assessment of a semi-automated software program for the identification of vertebral fractures in children
1The University of Sheffield, Sheffield, UK; 2Sheffield Children’s NHS Foundation, Sheffield, UK; 3Najran University, Najran, Saudi Arabia.
ba0006p079
Bone age assessment using Greulich and Pyle and Tanner-Whitehouse methods: a systematic review
1The University of Sheffield, Sheffield, UK; 2Sheffield Children’s NHS Foundation Trust, Sheffield, UK.
ba0006p080
Bone age determination using dual-energy X-ray absorptiometry
1Department of Oncology & Metabolism, The University of Sheffield, Sheffield, UK; 2Sheffield Children’s NHS Foundation Trust, Sheffield, UK.
ba0006p081
Impact of age, sex, location of injury, physical activity, vitamin D and calcium intake on the injury outcome of wrist and ankle in children
1University of Sheffield, Sheffield, UK; 2Najran University, Najran, Saudi Arabia; 3Sheffield Children’s NHS Foundation Trust, Sheffield, UK.
ba0006p082
Schmorl's node and vitamin D deficiency: cause or coincidence
1Department of Pediatrics, Medical Faculty, Erzincan University, Erzincan, Turkey; 2Department of Radiology, Regional Training and Research Hospıtal, Erzurum, Turkey; 3Department of Pediatric Endocrinology, Medical Faculty, Ataturk University, Erzurum, Turkey; 4Department of Radiology, Medical Faculty, Erzincan University, Erzincan, Turkey.
ba0006p083
Chronological age, height adjusted age and bone age: Which of them correlates better to bone mineral density in kidney-transplant recipient children?
1Clinical Epidemiology Unit, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico; 2Nephrology Research Laboratory, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico.
ba0006p084
Cumulative radiation exposure from diagnostic imaging and associated lifetime cancer risk in children with Osteogenesis Imperfecta
1Department of Endocrinology and Diabetes, Birmingham Children’s Hospital, Birmingham, UK; 2Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK; 3Radiation Protection Services (RRPPS) University Hospitals Birmingham, Birmingham, UK.
ba0006p085
Feasibility and reproducibility using HRpQCTII in children and adolescents
1Stanford University School of Medicine, Stanford, California, USA; 2University of California, San Francisco, California, USA.
ba0006p086
Cranial synostosis and Chiari 1 malformation in X-linked hypophosphatemic rickets
1Pediatric Endocrinology Department, Bicêtre Hospital, APHP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, Filière OSCAR and Platform of Expertise for Rare Diseases Paris, Le Kremlin Bicêtre, France; 2Pediatric Nephrology Department, Reference Center for Rare Renal Diseases and INSERM 1033, Lyon, France; 3Pediatric Radiology Department, Bicêtre Hospital, APHP, Le Kremlin Bicêtre, France; 4Pediatric Neurosurgery Department and INSERM 1033, Lyon, France; 5INSERM U1169, Le Kremlin Bicêtre, France.
ba0006p087
Normative data for lateral distal femur bone mineral density in children from 3 to 18 years of age using Lunar Prodigy absorptiometry
1Sainte Justine University Health Center, Montreal, Quebec, Canada; 2Shriners Hospital For Children, Montreal, Quebec, Canada; 3McGill University Health Center, Montreal, Quebec, Canada; 4Sainte Justine Research Center, Montreal, Quebec, Canada.
ba0006p088
Cross Calibration of GE Lunar DPX Pro and GE Lunar iDXA
Hirabai Cowasji Jehangir Medical Research Institute, Pune, Maharashtra, India.
ba0006p089
Intra-observer precision of vertebral height measurements using spine X-Rays And DXA in boys with Duchenne Muscular Dystrophy
1Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK; 2Paediatric Neurosciences Research Group, Department of Paediatric Neurology, Royal Hospital for Children, Glasgow, UK.
ba0006p090
Reliability and validity of DXA based images for measurement of height in children
1Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK; 2Paediatric Neurosciences Research Group, Department of Paediatric Neurology, Royal Hospital for Children, Glasgow, UK.
ba0006p091
A boy with spondylo-epiphyseal dysplasia tarda
Karadeniz Technical University, School of Medicine, Trabzon, Turkey.
ba0006p093
Bone health assessment in children with thalassaemia major
1Department of Endocrinology and Diabetes, Birmingham Women’s and Children’s Hospital NHS Foundation Trust, Birmingham, UK; 2Department of Paediatrics, Royal Stoke University Hospital, Stoke, UK; 3Department of Clinical and Laboratory, Haematology Women’s and Children’s Hospital NHS Foundation Trust, Birmingham, UK; 4Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
ba0006p094
Evaluation of the use of body quantitative computed tomography for the assessment of the tibia in children with Neurofibromatosis 1
1Manchester Metropolitan University, Manchester, UK; 2Royal Manchester Children’s Hospital, Manchester, UK; 3Academic Health Science Centre, Manchester University Hospital NHS Foundation Trust, Manchester, UK; 4Division of Informatics, Imaging & Data Sciences, Faculty of Biology, Medicine & Health, Manchester, UK; 5Mindways Software, Inc., Texas, USA; 6St. Mary’s Hospital, Manchester, UK; 7MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK; 8MRC Elsie Widdowson Laboratory, Cambridge, UK.
ba0006p097
Bone strength and microarchitectural deficits in children with cystinosis
1University of California, San Francisco, California, USA; 2Stanford University, Stanford, California, USA.
ba0006p099
Decreased bone turnover in HIV-infected children on antiretroviral therapy
1Columbia University, New York, New York, USA; 2University of the Witwatersrand, Johannesburg, South Africa.
ba0006p100
Do measures of adiposity and muscle cross-sectionally predict the health of weight-bearing bones in 11--12 year old Australian children?: A population-based study
1The University of Melbourne, Parkville, Victoria, Australia; 2Murdoch Childrens Research Institute, Parkville, Victoria, Australia; 3Department of Endocrinology and Diabetes, The Royal Children’s Hospital, Parkville, Victoria, Australia; 4Centre for Community Child Health, The Royal Children’s Hospital, Parkville, Victoria, Australia.
ba0006p102
Femoral fractures in infants -- comparison of a population-based and an osteogenesis imperfecta-cohort
1Children's Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland; 2Department of Radiology, Children’s Hospital, HUS Medical Imaging Center, University of Helsinki and Helsinki University Hospital (HUH), Helsinki, Finland.
ba0006p103
Dietary calcium deficiency contributes to the causation of nutritional rickets (NR) in the United Kingdom (UK): data from the British Paediatric Surveillance Unit (BPSU) NR survey
1Royal Manchester Children’s Hospital, Manchester, UK; 2Great Ormond Street Hospital for Children NHS Trust, London, UK; 3Northwick Park Hospital, London, UK; 4Royal Free London NHS Foundation, London, UK; 5Royal College of Paediatrics & Child Health, British Paediatric Surveillance Unit, London, UK; 6Children’s University Hospital, Temple Street, Dublin, Ireland; 7Royal Hospital for Sick Children, Glasgow, UK; 8Birmingham Children’s Hospital, Birmingham, UK.
ba0006p104
Low serum alkaline phosphatase is often not recognised by clinicians
1Royal National Orthopaedic Hospital, Stanmore, UK; 2Royal Manchester Children’s Hospital, Manchester, UK; 3Northwick Park Hospital, London, UK.
ba0006p105
Does growth hormone and estrogens prevent girls with Turner syndrome from increased fracture rates?
12nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic; 2Faculty of Physics and Mathematics, Charles University in Prague, Prague, Czech Republic.
ba0006p106
A case of a novel de novo PLS3 deletion, presenting with vertebral fractures and mild dysmorphism
1Department of bone and mineral metabolism, Institute of child health, Athens, Greece; 2Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; 3Department of Paediatrics, General Hospital of Chania, Chania, Greece; 42nd Paediatric Orthopaedic Clinic, Agia Sophia Children’s Hospital, Athens, Greece; 51st Paediatric University clinic, Agia Sophia Children’s Hospital, Athens, Greece.
ba0006p107
Genetic transmission of osteogenesis imperfecta type V by a healthy mosaic carrier father
1Center for Medical Genetics, Ghent University, Ghent, Belgium; 2Department of Radiology, Medical University, Innsbruck, Austria; 3Department of Pediatrics I, Medical University, Innsbruck, Austria.
ba0006p108
Microdeletion of 12p11.22-p11.21 resulting in a skeletal dysplasia characterized by significant metaphyseal abnormalities and osteolysis
1University of Toronto, Hospital for Sick Children, Toronto, ON, Canada; 2University of Washington, Seattle, Washington, USA.
ba0006p109
Case report: a potentially new skeletal dysplasia with autosomal recessive inheritance
1Institute for Human Genetics, Julius Maximilians University, Würzburg, Germany; 2Monogenic Molecular Genetics, University of Exeter Medical School, Exeter EX1 2LU, UK.
ba0006p110
Vitamin D-dependent rickets type 1 due to a novel mutation in CYP27B1
1Pediatric Endocrinology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel-Hashomer, Israel; 2Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; 3The Institute for Rare Diseases, The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel-Hashomer, Israel; 4Department of Pediatrics A, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel-Hashomer, Israel; 5Sheba Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Israel; 6Pediatric Imaging Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel-Hashomer, Israel; 7Department of Pediatric Intensive Care, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
ba0006p111
A novel mutation of CYP27B1 in two siblings with vitamin D-dependent rickets type 1A
Ataturk University, Medical Faculty Department of Pediatric Endocrinology, Erzurum, Turkey.
ba0006p112
Rare copy number variants in array-based comparative genomic hybridization in early-onset skeletal fragility
1Karolinska Institutet, Stockholm, Sweden; 2University of Oulu, Oulu, Finland; 3University of Helsinki, Helsinki, Finland.
ba0006p114
Classical SATB2-associated syndrome with severe osteoporosis, recurrent bony fractures and tibial bowing
1Royal National Orthopaedic Hospital, Stanmore, UK; 2Northwick Park Hospital, London, UK; 3Royal Manchester Childrens Hospital, Manchester, UK.
ba0006p116
Genome-wide association study identifies five novel genetic determinants of dental maturation
1The Generation R Study Group, Rotterdam, The Netherlands; 2Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands; 3Department of Oral & Maxillofacial Surgery, Special Dental Care and Orthodontics, Erasmus MC, Rotterdam, The Netherlands; 4NFBC1966/Lifecourse Epidemiology, Imperial College, London, UK; 5ALSPAC/MRC Integrative Epidemiology Unit, Bristol University, Bristol, UK; 6Diamantina Institute, University of Queensland/AU, Queensland, Australia.
ba0006p118
Phenotypic spectrum in Weyers acrofacial dysostosis: A case report
Health Sciences Department, University of Florence, Anna Meyer Children’s University Hospital, Florence, Italy.
ba0006p119
Vitamin D-dependent rickets - a rare form of rickets - diagnostics and therapeutic problem
Department of Pediatric Propedeutics and Bone Metabolic Diseases Medical University of Lodz, Lodz, Poland.
ba0006p120
Bisphosphonate treatment initiated in the newborn period - our experience
1Department of Children and Adolescents, Third Faculty of Medicine, Charles University, Prague, Czech Republic; 2Department of Pediatrics, Thomayer Hospital of Prague, Prague, Czech Republic; 3Department of Pediatrics, Hospital of Ceske Budejovice, Ceske Budejovice, Czech Republic.
ba0006p122
The treatment of Hyperphosphatemic Familial Tumoral Calcinosis
1Departments of Pediatrics, Children’s Hospital of Eastern Ontario, and The University of Ottawa, Ottawa, Canada; 2Department of Surgery, Children’s Hospital of Eastern Ontario, and The University of Ottawa, Ottawa, Canada.
ba0006p124
A case of severe reaction following the use of Bisphosphonates in a patient with Osteogenesis Imperfecta
1Alder Hey Children’s Hospital, Liverpool, UK; 2Sheffield Children’s Hospital, Sheffield, UK.
ba0006p126
Growth hormone treatment in two short peri-pubertal brothers with X-linked hypophosphatemic rickets
1The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel; 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; 3Institute of Nephrology, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel.
ba0006p127
The case of severe osteoporosis in patient with recessive dystrophic Epidermolysis Bullosa
D. F. Chebotarev Institute of Gerontology, NAMS of Ukraine, Kyiv, Ukraine.
ba0006p129
The impact of intravenous bisphosphonate on vertebral morphometry in children with secondary osteoporosis and vertebral fractures
1Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK; 2Paediatric Neurosciences Research Group, Department of Paediatric Neurology, Royal Hospital for Children, Glasgow, UK.
ba0006p130
The treatment of Camurati-Engelmann disease with Losartan: a case report
1Royal National Orthopaedic Hospital, Stanmore, UK; 2Northwick Park Hospital, London, UK; 3Royal Manchester Children’s Hospital, Manchester, UK.
ba0006p131
Anti-RANKL treatment in a murine model of fibrous dysplasia
1Sapienza University of Rome, Rome, Italy; 2NIDCR, NIH, Bethesda, USA.
ba0006p132
Long term treatment with intravenous pamidronate in two children with severe form of juvenile Paget's disease
1Pediatric Endocrinology, Universitätsklinikum Essen, Essen, Germany; 2Pediatric Hematology and Oncology, Universitätsklinikum Essen, Essen, Germany; 3Center for Rare Bone Disease, Universitätsklinikum Essen, Essen, Germany; 4Department for Orthopaedics and Emergency Surgery, Universitätsklinikum Essen, Essen, Germany.
ba0006p133
Continuous subcutaneous PTH infusion in autosomal dominant hypocalcaemia
1Department of Paediatric Endocrinology, Queen Mary University London and Barts Health NHS Trust, London, UK; 2Department of Paediatrics, Ipswich Hospital, Ipswich, UK; 3Department of Nephrology, Barts Health NHS Trust, London, UK; 4Academic Endocrine Unit, University of Oxford, Oxford, UK; 5Department of Endocrinology, Great Ormond Street Hospital, London, UK.
ba0006p135
Preliminary results for a ramping model of pamidronate administration
1Nemours/A.I. duPont Hospital for Children, Wilmington, Delaware, USA; 2University of Delaware, Newark, Delaware, USA.
ba0006p136
Growth, bone and muscle mass are adversely affected in bone marrow transplant recipients: a body composition analysis
1Department of Bone and Mineral Metabolism, Institute of Child Health, Athens, Greece; 2Department of Endocrinology, Growth and Development, “P.&A. Kyriakou” Children’s Hospital, Athens, Greece; 3Bone Marrow Transplant Unit, Oncology Unit M. V. Vardinogianni “ELPIDA”, “Agia Sophia” Children’s Hospital, Athens, Greece; 4Biostatistician, Athens, Greece.
ba0006p137
Fibrodysplasia ossificans progressiva: baseline characteristics of 101 subjects participating in a global, longitudinal, natural history study
1Center for Research in FOP and Related Disorders, The University of Pennsylvania, Philadelphia, Pennsylvania, USA; 2Division of Endocrinology and Metabolism, University of California, San Francisco, California, USA; 3Hopital Necker-Enfants Malades Centre de Reference Maladies Osseuses Constitutionnelles Departement de Genetique, Paris, France; 4Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia; 5Department of Pediatrics, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; 6Unit of Rare Diseases, Department of Pediatrics, IRCCS Giannina Gaslini, Genoa, Italy; 7Royal National Orthopaedic Hospital, Stanmore, UK; 8Clementia Pharmaceuticals Inc., Boston, Massachusetts, USA; 9Division of Geriatric Medicine and Gerontology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
ba0006p138
Relative impact of muscle strength and muscle mass on bone mineral density in Japanese adolescents: data from the Kitakata Kids Health Study
1Department of Public Health, Kindai University Faculty of Medicine, Osaka-Sayama, Japan; 2Department of Health and Nutrition, Faculty of Human Life, Jin-ai University, Echizen, Japan; 3Department of Orthopedic Medicine, Second Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China; 4Department of Health Promotion and Education, Graduate School of Human Development and Environment, Kobe University, Kobe, Japan.
ba0006p139
Gender differences in bone health in a cohort of adolescents with developmental coordination disorder
1Institute for Health Research, University of Notre Dame, Fremantle, Australia; 2Institute for Physical Activity and Nutrition, Deakin University, Melbourne, Australia; 3School of Health Sciences, University of Notre Dame, Fremantle, Australia; 4Menzies Health Institute Queensland, School of Allied Health Sciences, Griffith University, Gold Coast, Australia; 5Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Australia; 6Department of Endocrinology and Diabetes, Princess Margaret Hospital, Subiaco, Australia.
ba0006p143
Soft tissues, areal bone mineral density and hip geometry estimates in active young boys: the PRO-BONE study
1University of Exeter, Exeter, UK; 2Brock University, Ontario, Canada; 3University of Castilla-La Mancha, Toledo, Spain; 4University of São Paulo, São Paulo, Brazil; 5University of Zaragoza, Zaragoza, Spain.
ba0006p144
Longitudinal growth and bone development in glucocorticoid treated boys with Duchenne muscular dystrophy
1Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK; 2Paediatric Neurosciences Research Group, Department of Paediatric Neurology, Royal Hospital for Children, Glasgow, UK.
ba0006p145
Stature and longitudinal growth in glucocorticoid naive boys with Duchenne Muscular Dystrophy
1Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK; 2Paediatric Neurosciences Research Group, Department of Paediatric Neurology, Royal Hospital for Children, Glasgow, UK; 3Scottish Muscle Network, Queen Elizabeth University Hospital, Glasgow, UK; 4Department of Paediatrics, Forth Valley Royal Hospital, Stirling, UK; 5Department of Paediatric Neurology, Royal Hospital for Sick Children, Edinburgh, UK; 6Department of Paediatrucs, Ninewells Hospital, Dundee, UK; 7Department of Paediatrics, Royal Aberdeen Children’s Hospital, Aberdeen, UK.
ba0006p146
Bone health in boys with Duchenne muscular dystrophy (DMD): the dichotomy between bone density and fracture
1Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK; 2Institute of Metabolism and Systems Research, Birmingham, UK; 3Heart of England NHS Foundation Trust, Birmingham, UK.
ba0006p147
DXA based evaluation of the bone mass and body composition in a group of Romanian cystic fibrosis children
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; 2‘Alfred Russescu’ National Institute for Mother and Child Health, Bucharest, Romania; 3Academica Medical Center, Bucharest, Romania.
ba0006p150
Characterisation of skeletal developmental in mouse models of Duchenne Muscular Dystrophy
1Department of Developmental Biology, Roslin Institute, Edinburgh University, UK; 2Developmental Endocrinology Research Group, University of Glasgow, UK; 3John Walton Muscular Dystrophy Research Centre, Newcastle University, UK.
ba0006p151
Seasonal variation in internet searches for vitamin D
1MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, Hampshire, UK; 2Paediatric Endocrinology, University Hospital Southampton NHS Foundation Trust, Southampton, Hampshrie, UK; 3NIHR Southampton Nutrition Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, UK; 4NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, Oxfordshire, UK.
ba0006p152
Vitamin D intake and status in children 2-18 years: a meta-analysis
McGill University, Sainte-Anne-de-Bellevue, QC, Canada.
ba0006p153
Maximal suppression of parathyroid hormone as a determinant of optimal vitamin D status in adolescents
1University of Surrey, Guildford, UK; 2University of Copenhagen, Copenhagen, Denmark; 3University College Cork, Cork, Ireland.
ba0006p154
Dietary protein is associated with bone adaptations and performance of pre-adolescents
1Democritus University of Thrace, Komotini, Greece; 2University of Thessaly, Trikala, Greece; 3University of Athens, Athens, Greece; 4University of Exeter, Exeter, UK; 5University of Zaragoza, Zaragoza, Spain.
ba0006p155
Bone health status of underprivileged Indian adolescent girls
1Hirabai Cowasji Jehangir Medical Research Institute, Pune, Maharashtra, India; 2Royal Manchester Children’s Hospital, Manchester, UK.
ba0006p156
Are there gender differences in abdominal fat distribution in healthy teenagers?
1INSERM 1033, Lyon, France; 2EPICIME, Lyon, France; 3Pediatric Nephrology, Bron, France.
ba0006p157
Bone metabolism in adolescent girls with anorexia nervosa
Paediatrics Department of Faculty of Medicine Comenius University in Bratislava, SR, Bratislava, Slovakia.
ba0006p158
Maternal calcium supplementation in a rural Gambian population associated with reduced blood pressure among adolescent female, but not male, offspring
1MRC Elsie Widdowson Laboratory, Cambridge, UK; 2Division of Women’s Health, King’s College London, London, UK; 3MRC Unit The Gambia, Banjul, Gambia; 4MRC Lifecourse Epidemiology Unit, Southampton, UK.
ba0006p159
Maternal calcium supplementation in a rural Gambian population associated with reduced height and weight among adolescent female, but not male, offspring
1MRC Elsie Widdowson Laboratory, Cambridge, UK; 2Division of Women’s Health, King’s College London, London, UK; 3MRC Unit The Gambia, Banjul, Gambia; 4MRC Lifecourse Epidemiology Unit, Southampton, UK.
ba0006p160
Early-life vitamin D status and bone mass at five years in a prospective birth cohort study
1Cork Centre for Vitamin D and Nutrition Research, School of Food and Nutritional Sciences, University College Cork, Cork, Ireland; 2The Irish Centre for Fetal and Neonatal Translational Research (INFANT), University College Cork, Cork, Ireland; 3Department of Paediatrics and Child Health, University College Cork, Cork, Ireland; 4Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland; 5Department of Clinical Medicine, Trinity College, Dublin, Ireland; 6Department of Paediatric Dermatology, Our Lady’s Children’s Hospital, Dublin, Ireland; 7National Children’s Research Centre, Our Lady’s Children’s Hospital, Dublin, Ireland.
ba0006p161
Nutritional rickets presenting to secondary care in children (<16 years) -- A UK surveillance study
1Royal Free Hospital, London, UK; 2British Paediatric Surveillance Unit, London, UK; 3Royal Manchester Children’s Hospital, Manchester, UK; 4Birmingham Children’s Hospital, Birmingham, UK; 5Royal Hospital for Sick Children Glasgow, Glasgow, UK; 6Children’s University Hospital, Dublin, Ireland; 7Northwick Park Hospital, London, UK; 8Great Ormond Street Hospital, London, UK.
ba0006p162
Orthopaedic management of leg length discrepancy in Proteus syndrome: a case series
1National Institues of Health/National Human Genome Research Institute, Bethesda, Maryland, USA; 2Children’s National Health System, Washington, District of Columbia, USA; 3Shriners Hospital for Children – Houston, Houston, Texas, USA.
ba0006p169
Physical activity is negatively correlated with circulating sclerostin in 6--12 year-old children
1Democritus University of Thrace, Komotini, Greece; 2University of Thessaly, Trikala, Greece; 3KAT General Hospital, Athens, Greece; 4University of Athens, Athens, Greece; 5University of Exeter, Exeter, UK; 6University of Zaragoza, Zaragoza, Spain.
ba0006p170
Bone health at 11-12 years, physical activity and sedentariness: a cross-sectional Australian population-based study
1University of Melbourne, Parkville, Victoria, Australia; 2Murdoch Childrens Research Institute, Parkville, Victoria, Australia; 3Department of Endocrinology and Diabetes, The Royal Children’s Hospital, Parkville, Victoria, Australia; 4Alliance for Research in Exercise, Nutrition and Activity (ARENA), University of South Australia, Parkville, Victoria, Australia; 5Centre for Community Child Health, The Royal Children’s Hospital, Parkville, Victoria, Australia.
ba0006p172
Maffucci syndrome - as an extremely rare form of Ollier disease
Institute of Orthopedics and Traumatology, Kiev, Ukraine.
ba0006p174
Management of Gorham disease in the cervicothoracic spine with mobile gravity traction and Sirolimus
1Royal National Orthopaedic Hospital, Stanmore, UK; 2Royal Manchester Childrens Hospital, Manchester, UK.
ba0006p175
The elbow in type V osteogenesis imperfecta: is early functional loss related to radiographic findings?
1Sheffield Children’s NHS Foundation Trust, Sheffield, UK; 2University of Sheffield, Sheffield, UK.
ba0006p177
Skeletal health of young patients with perinatal HIV infection: Experience from a reference center
1Department of Bone and Mineral Metabolism, Institute of Child Health, Athens, Greece; 2Department of Paediatrics, University of Athens Medical School, Athens, Greece; 3Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), The “Stavros Niarchos” Foundation, Athens, Greece; 4Biostatistician, Athens, Greece.
ba0006p179
Generalized arterial calcinosis of infancy: a case of a new mutation with central nervous system involvement and good response to bisphosphonates
1Department of Bone and Mineral Metabolism, Institute of Child Health, Athens, Greece; 2Neonatal Intensive Care Unit, P.&A. Kyriakou Children’s Hospital, Athens, Greece; 3Department of Radiology, P.&A. Kyriakou Children’s Hospital, Athens, Greece; 4Department of Paediatric Cardiology, P.&A. Kyriakou Children’s Hospital, Athens, Greece.
ba0006p181
Osteonecrosis results in significant long term morbidity in patients with acute lymphoblastic leukaemia
1Leeds Children’s Hospital, Leeds, UK; 2University of Leeds, Leeds, UK; 3Sheffield Children’s Hospital, Sheffield, UK.
ba0006p182
Physical activity and health-related quality of life in patients with chronic non-bacterial osteomyelitis - pilot and model project in a rare inflammatory bone disease
1Pediatric Rheumatology and Osteology, University Children’s Hospital, Wuerzburg, Germany; 2Children’s Hospital, Vivantes Hospital im Friedrichshain, Berlin, Germany; 3Pediatric Pulmonology and Sports Medicine, University Children’s Hospital, Wuerzburg, Germany.
ba0006p184
Effects of vitamin D with calcium supplementation or zinc supplementation on the incidence of infections in school children: a randomized controlled trial
1Hirabai Cowasji Jehangir Medical Research Institute, Pune, Maharashtra, India; 2Royal Manchester Children’s Hospital, Manchester, UK.
ba0006p185
Is cherubism a systemic disease? Prospective study about 9 patients
1Hôpital Necker-Enfants Malades, Paris, France; 2Laboratoire physiopathologie orale moléculaire INSERM 1138, Paris, France.
ba0006p186
Acroosteolysis presenting as nail resorption
KK Women’s & Children’s Hospital, Singapore, Singapore.
ba0006p187
Paradoxical response of serum parathyroid hormone concentration in response to vitamin D and calcium supplementation in undernourished Indian children
1Hirabai Cowasji Jehangir Medical Research Institute, Pune, Maharashtra, India; 2Royal Manchester Children’s Hospital, Manchester, UK.
ba0006p188
A deep phenotyping of autosomal dominant osteopetrosis type 2 (ADO2) mouse model revealed multiorgan dysfunctions
Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy.
ba0006p189
Development of an in vitro model of cancer stem cells from a rare human telangiectatic osteosarcoma
1Department of Surgery and Translational Medicine, University of Florence, Florence, Italy; 2Department of Neurofarba, University of Florence, Florence, Italy; 3SOD Ortopedia Oncologica e Ricostruttiva, AOU Careggi, Florence, Italy; 4Clinica universitaria Ortopedia e Traumatologia, Azienda Ospedaliera, Pisa, Italy.
ba0006p190
Juvenile hypophosphatasia presenting with short stature: a case report
School of Medicine, Celal Bayar University, Manisa, Turkey.
ba0006p191
Development of an osteogenesis imperfecta specific quality of life measure
1Sheffield Children’s NHS Trust, Sheffield, UK; 2University of Sheffield, Sheffield, UK.
ba0006p192
Concentrated growth factor for the treatment of intrabony defects in chronic periodontitis in adolescents
1Department of Periodontology, Dental Faculty, Ataturk University, Erzurum, Turkey; 2Department of Pediatric Endocrinology, Medical Faculty, Ataturk University, Erzurum, Turkey.
ba0006p195
A qualitative enquiry examining the lived experience of mothers who have children with osteogenesis imperfecta
1The University of Sheffield, Sheffield, UK; 2Sheffield Children’s NHS Foundation Trust, Sheffield, UK.
ba0006p196
Osteosarcoma-derived Extracellular Vesicles induce tumoral-like phenotypes in normal cells
1University of Rome – Sapienza, Rome, Italy; 2Bambino Gesù Children Hospital – Multifactorial Diseases Unit, Rome, Italy.
ba0006p202
Is a modified version of the Childhood Health Assessment Questionnaire (CHAQ) a useful tool to identify the level of disability in children with osteogenesis imperfecta?
1Department Endocrinology and Diabetes, Birmingham Children’s Hospital, Birmingham, UK; 2Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
ba0006p204
Osteopathologies and endocrine late effects in a cohort of 102 juvenile survivors of brain tumors
1Department of Pediatric Hematology and Oncology, Kinderklinik III, Universitätsklinikum-Essen and the University of Duisburg-Essen, Essen, Germany; 2Department of Pediatric Endocrinology and Diabetology, Kinderklinik II, Universitätsklinikum-Essen and the University of Duisburg-Essen, Essen, Germany.
ba0006p205
Bone turnover in the obese children is related to gender, body compo-sition and leptin level
1Department of Pediatrics and Pediatric Endocrinology, Medical University of Silesia, Katowice, Poland; 2Department of Pathophysiology, Medical University of Silesia, Katowice, Poland; 3Department of Medical Rehabilitation, Medical University of Silesia, Katowice, Poland.
ba0006p207
Social barriers and needs of children with osteogenesis imperfecta (OI): a qualitative descriptive interview-based study
Medical University of Bialystok, Department of Pediatrics, Rheumatology, Immunology and Metabolic Bone Diseases, Bialystok, Poland.
ba0006p208